# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-23-049299
Filing Date
2023-04-25
Accepted
2023-04-25 08:01:23
Documents
19

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | tm231848d2_def14a.htm iXBRL | DEF 14A | 1309115
6 | GRAPHIC | bc_paidvsyearendcash-4c.jpg | GRAPHIC | 175337
7 | GRAPHIC | bc_paidvsnetloss-4c.jpg | GRAPHIC | 160383
8 | GRAPHIC | px_01page-bw.jpg | GRAPHIC | 952084
9 | GRAPHIC | px_02page-4c.jpg | GRAPHIC | 637257
10 | GRAPHIC | bc_paidvstsr-4c.jpg | GRAPHIC | 168620
| Complete submission text file | 0001104659-23-049299.txt |  | 6882382

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
2 | XBRL TAXONOMY EXTENSION SCHEMA | cldx-20221231.xsd | EX-101.SCH | 9255
3 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | cldx-20221231_def.xml | EX-101.DEF | 4402
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | cldx-20221231_lab.xml | EX-101.LAB | 17100
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | cldx-20221231_pre.xml | EX-101.PRE | 3384
13 | EXTRACTED XBRL INSTANCE DOCUMENT | tm231848d2_def14a_htm.xml | XML | 171142

Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

EIN.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-15006 | Film No.: 23841804
SIC: 2835 In Vitro & In Vivo Diagnostic Substances